David Hough
Chief Tech/Sci/R&D Officer presso PAXMEDICA, INC.
Patrimonio netto: 3 012 $ in data 31/03/2024
Profilo
David Hough is currently the Chief Medical Officer at PaxMedica, Inc. He previously worked as the Vice President at Janssen Research & Development LLC from 2002 to 2020.
He also worked as the Chief Medical Officer at PaxMedica, Inc. from 2020 to 2022.
Dr. Hough received his undergraduate degree from the US Military Academy.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PAXMEDICA, INC.
0.08% | 15/03/2024 | 5 905 ( 0.08% ) | 3 012 $ | 31/03/2024 |
Posizioni attive di David Hough
Società | Posizione | Inizio |
---|---|---|
PAXMEDICA, INC. | Chief Tech/Sci/R&D Officer | 16/08/2023 |
Precedenti posizioni note di David Hough
Società | Posizione | Fine |
---|---|---|
PAXMEDICA, INC. | Corporate Officer/Principal | 01/04/2022 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01/01/2020 |
Formazione di David Hough
US Military Academy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PAXMEDICA, INC. | Health Technology |
Aziende private | 1 |
---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
- Borsa valori
- Insiders
- David Hough